Details for New Drug Application (NDA): 072692
✉ Email this page to a colleague
NDA 072692 describes NORTREL 0.5/35-21, which is a drug marketed by Barr and is included in one NDA. Additional details are available on the NORTREL 0.5/35-21 profile page.
The generic ingredient in NORTREL 0.5/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in NORTREL 0.5/35-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 072692
| Tradename: | NORTREL 0.5/35-21 |
| Applicant: | Barr |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.035MG;0.5MG | ||||
| Approval Date: | Feb 28, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
